A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes

Archives of Internal Medicine

Volumn 156, Issue 10, 1996, Pages 1047-1052

  Godfrey, Robert G ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DOXEPIN; TRICYCLIC ANTIDEPRESSANT AGENT;

BEHAVIOR MODIFICATION; CARDIOVASCULAR DISEASE; CHRONIC PAIN; DRUG CONTRAINDICATION; DRUG MECHANISM; ENDOCRINE DISEASE; EXERCISE; FIBROMYALGIA; GASTROINTESTINAL SYMPTOM; HUMAN; LIFESTYLE; NEUROTOXICITY; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; REVIEW; SKIN MANIFESTATION; TREATMENT OUTCOME;

AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHRONIC DISEASE; DOXEPIN; FIBROMYALGIA; HUMANS; LIFE STYLE; PAIN; SYNDROME;

EID: 0029890354     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.10.1047     Document Type: Review

References (44)

1. Hendler N. The anatomy and psychopharmacology of chronic pain. J Clin Psychiatry. 1982;43: 15-20.
2. Tollison CD, Kriegel MA. Selected tricyclic antidepressants in the management of chronic benign pain. South Med J. 1988;81:562-564.
3. Frank RG, Kashani JH, Parker JC, et al. Antidepressant analgesia in rheumatoid arthritis. J Rheumatol. 1988;15:1632-1638.
4. Tollison CD. Antidepressant use in patients with chronic pain. Drug Ther. November 1990:50-57.
5. Miller DR, Seifert RD. Management of fibromyalgia, a distinct rheumatologic syndrome. Clin Pharmacol. 1987;6:778-786.
6. Pilowsky I, Hallett EC, Bassett OL, Thomas PG, Penhall RK. A controlled study of amitriptyline in the treatment of chronic pain. Pain. 1982;14: 169-179.
7. Carette S, McCain GA, Bell DA, Fam AG. Evaluation of amitriptyline in primary fibrositis. Arthritis Rheum. 1986;29:655-659.
8. Jaeschke R, Adachi J, Guyatt G, Keller J, Wong B. Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rtheumatol. 1991;18:447-451.
9. Goldenberg DL, Felson DT, Dinerman H. A randomized, controlled trial of amitriptyline and naproxen in patients with fibromyalgia. Arthritis Rheum. 1986;29:1371-1377.
10. Bennett RM, Gatter RA, Campbell SM, Andrews RP, Clark SR, Scarola JA. A comparison of cyclobenzaprine and placebo in the management of fibrositis: a double-blind controlled study. Arthritis Rheum. 1988;31:1535-1542.
11. Reynolds JW, Moldofsky H, Saskin P, Lue FA. The effect of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia. J Rtheumatol. 1991;18:452-454.
12. Fordyce WE. Cognitive and behavioral treatment of chronic pain and disability. In: Foley KM, Payne RM, eds. Current Therapy Series: Current Therapy of Pain. Philadelphia, Pa: BC Decker Inc; 1989:7-13.
13. Foley KM, Payne RM, eds. Current Therapy Series: Current Therapy of Pain. Philadelphia, Pa: BC Decker Inc; 1989.
14. Goodman WK, Charney DS. Therapeutic applications and mechanisms of action of monoamine oxidase inhibition and heterocyclic antidepressant drugs. J Clin Psychiatry. 1985;46:6-22.
15. Getto CJ, Sorkness CA, Howell T. Antidepressants and chronic nonmalignant pain: a review. J Pain Symptom Manage. 1987;2:9-18.
16. US Pharmacopeial Conventions Drug Information Division Advisory Panels. Drug Information for the Health Care Professional (USP DI). 12th ed. Rockville, Md: US Pharmacopeial Conventions Inc; 1992:IA.
17. Magni G. The use of antidepressants in the treatment of chronic pain. Drugs. 1991;42:730-748.
18. Watson CPN. Antidepressant drugs as adjuvant analgesics. J Pain Symptom Manage. 1994;9: 392-405.
19. Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In: Gilman AG, Rail TW, Nies AS, Taylor P, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. Elmsford, NY: Pergamon Press Inc; 1990:404.
20. Ayd FJ Jr. Five to fifteen years' maintenance doxepin therapy. Int Clin Psychopharmacol. 1986; 1:53-65.
21. Carette S, Bell MJ, Reynolds WJ, et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. Arthritis Rheum. 1994;37:32-40.
22. Hauri PJ, Esther MS. Insomnia. Mayo Clin Proc. 1990;65:869-882.
23. Richelson E. Antidepressants and brain neurochemistry. Mayo Clin Proc. 1990;65:1227-1236.
24. Yunus MS. Towards a model of pathophysiology of fibromyalgia: aberrant pain mechanisms with peripheral modulation. J Rheumatol. 1992; 19:846-849.
25. Feinmann C. Pain relief by antidepressants: possible modes of action. Pain. 1985;23:1-8.
26. Sacerdote P, Brini A, Mantegazza P, Panerai AE. A role for serotonin and beta-endorphin in the analgesia induced by some tricyclic antidepressant drugs. Pharmacol Biochem Behav. 1987; 26:153-158.
27. Rudorfer MV, Potter WZ. Antidepressants: a comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the Older' drugs. Drugs. 1989;37:713-738.
28. Potter WZ, Rudorfer MV, Manji H. The pharmacologic treatment of depression. N Engl J Med. 1991;325:633-642.
29. Henriksson KG. Chronic muscular pain: aetiology and pathogenesis. Baillieres Clin Rheumatol. 1994;8:703-719.
30. American Medical Association Department of Drugs, Division of Drugs, and Toxicology. Drug Evaluations Annual 1991 (AMA DE). Chicago, III: American Medical Association; 1991.
31. Max MB ,Lynch AS, Muir MJ, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992;326.1250-1256.
32. Wolfe F, Cathey MA, Hawley DJ. A double-blind controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol. 1994;23:255-259.
33. Goldenberg DL, Mayskly M, Mossey C, Ruthazer R, Schmid C. The independent and combined efficacy of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 1995;38 (suppl 9):S229. Abstract.
34. Hayes JR, Bojrab SL, McCarthy MC. Gastrointestinal effects of tricyclic antidepressants: Olgivie's syndrome. Psychosomatics. 1987;28:442-443.
35. Goldenberg DL. Review of the role of tricyclic medications in the treatment of fibromyalgia syndrome. J Rheumatol. 1989;16(suppl 19):137-139.
36. Bennett RM, Smythe HA, Wolfe F. Recognizing fibromyalgia. Patient Care. July 15, 1989:60-83.
37. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum. 1990;33:160-172.
38. Russell IJ, Fletcher EM, Michalek JE, McBroom PC, Hester GG. Treatment of primary fibrositis/ fibromyalgia syndrome with ibuprofen and alprazolam: a double-blind, placebo-controlled study. Arthritis Rheum. 1991;34:552-560.
39. Diamond S. Vascular headache. In: Foley KM, Payne RM, eds. Current Therapy of Pain. Philadelphia, Pa: BC Decker Inc; 1989:181.
40. Payne R. Medication-induced performance deficits: analgesics and narcotics. J Occupat Med. 1990;32:362-369.
41. Richlin DM. Nonnarcotic analgesics and tricyclic antidepressants for the treatment of chronic nonmalignant pain. Mt Sinai J Med. 1991;56: 221-228.
42. McCain GA, Mai FM, Halliday PD. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum. 1988;31:1135-1140.
43. Royal Canadian Air Force Staff. Royal Canadian Air Force Exercise Plan for Physical Fitness. New York, NY: Simon & Schuster Inc Publishers; 1978.
44. White KP, Nielson WR. Cognitive behavioral treatment of fibromyalgia syndrome: a follow-up assessment. J Rheumatol. 1995;22:717-721.